Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hepatology
Volume 2014, Article ID 584650, 7 pages
http://dx.doi.org/10.1155/2014/584650
Research Article

Targeting Interleukin-4 Receptor Alpha by Hybrid Peptide for Novel Biliary Tract Cancer Therapy

1Department of Oral and Maxillofacial Surgery, Clinical Sciences, University of Tsukuba, Ibaraki 305-8575, Japan
2Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan
3Medical Science, Faculty of Medicine, University of Tsukuba, Ibaraki 305-8575, Japan
4Division of Biomedical Science, Faculty of Medicine, University of Tsukuba, Ibaraki 305-8575, Japan
5Department of Human Pathology, Graduate School of Medical Science, Kanazawa University, Kanazawa 920-1192, Japan

Received 7 February 2014; Accepted 8 April 2014; Published 27 April 2014

Academic Editor: Chawalit Pairojkul

Copyright © 2014 Kahori Seto et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Kahori Seto, Junichi Shoda, Tomohisa Horibe, et al., “Targeting Interleukin-4 Receptor Alpha by Hybrid Peptide for Novel Biliary Tract Cancer Therapy,” International Journal of Hepatology, vol. 2014, Article ID 584650, 7 pages, 2014. https://doi.org/10.1155/2014/584650.